Glucagon (Baqsimi)

Trade Name : Baqsimi

Eli Lilly and Company

POWDER

Strength 3 mg/1

GLUCAGON Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Glucagon (Baqsimi) which is also known as Baqsimi and Manufactured by Eli Lilly and Company. It is available in strength of 3 mg/1 per ml. Read more

Glucagon (Baqsimi) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price. Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

About GNH

No data

BAQSIMIu2122 is indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 years and above.n
BAQSIMIu2122 is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 years and above. ()n

No data

BAQSIMI is for intranasal use only. ()n
The recommended dose of BAQSIMI is 3u00a0mg administered as one actuation of the intranasal device into one nostril. ()n
Administer BAQSIMI according to the printed instructions on the shrink-wrapped tube label and the Instructions for Use. ()n
Administer the dose by inserting the tip into one nostril and pressing the device plunger all the way in until the green line is no longer showing. The dose does not need to be inhaled. ()n
Call for emergency assistance immediately after administering the dose. ()n
When the patient responds to treatment, give oral carbohydrates. ()n
Do not attempt to reuse BAQSIMI. Each BAQSIMI device contains one dose of glucagon and cannot be reused. ()n
If there has been no response after 15 minutes, an additional 3u00a0mg dose may be administered while waiting for emergency assistance. ()n

Nasal Powder:n
Nasal powder: intranasal device containing one dose of glucagon 3u00a0mg ()n

BAQSIMI is contraindicated in patients with:n

Pheochromocytoma ()n
Insulinoma ()n
Known hypersensitivity to glucagon or to any of the excipients ()n

No data

Catecholamine Release in Patients withnn- Pheochromocytoma
4n- 5.1
Lack of Efficacy in Patients withnn- Insulinoma
4n- 5.2
Arrayn- Hypersensitivity and Allergic Reactions
4n- 5.3
Lack of Efficacy in Patients with Decreased Hepaticnn- Glycogen

The following serious adverse reactions are described below and elsewhere in labeling:n
Most common (u226510%) adverse reactions associated with BAQSIMI are nausea, vomiting, headache, upper respiratory tract irritation (i.e., rhinorrhea, nasal discomfort, nasal congestion, cough, and epistaxis), watery eyes, redness of eyes, itchy nose, throat and eyes. ()n
To report SUSPECTED ADVERSE REACTIONS, contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

No data

Arrayn- Beta-blockers
Arrayn- Indomethacin
Arrayn- Warfarin

No data

If overdosage occurs, the patient may experience nausea, vomiting, inhibition of GI tract motility, increase in blood pressure and pulse rate. In case of suspected overdosing, serum potassium levels may decrease and should be monitored and corrected if needed. If the patient develops a dramatic increase in blood pressure, phentolamine mesylate has been shown to be effective in lowering blood pressure for the short time that control would be needed.n

BAQSIMI contains glucagon, an antihypoglycemic agent used to treat severe hypoglycemia. Glucagon is a single-chain polypeptide containing 29 amino acid residues and has a molecular weight of 3483, and is identical to human glucagon.n
Its molecular formula is CHNOS, with the following molecular structure:n
BAQSIMI is a preservative-free, white powder for intranasal administration in an intranasal device containing one dose of 3u00a0mg glucagon. BAQSIMI contains glucagon as the active ingredient and betadex, and dodecylphosphocholine as the excipients.n

No data

Long term studies in animals to evaluate carcinogenic potential have not been performed. Recombinant glucagon was positive in the bacterial Ames assay. It was determined that an increase in colony counts was related to technical difficulties in running this assay with peptides. Studies in rats have shown that glucagon does not cause impaired fertility.n

No data

BAQSIMI is supplied as an intranasal device containing one 3u00a0mg dose of glucagon as a preservative free, white powder.n

Advise the patient and family members or caregivers to read the FDA-approved patient labeling ( and ).n

BAQ-0001-PPI-20190724n

INSTRUCTIONS FOR USE
BAQSIMIu2122
(glucagon) nasal powdern
3u00a0mgn
Read the Instructions for Use for BAQSIMI before using it.n- They need to know how to use BAQSIMI before an emergency happens.
Important Information to Know
Preparing the Dose
Giving the Dose
After giving BAQSIMI
Storage and Handling
Other Information
For Questions or More Information about BAQSIMI
BAQSIMI is a trademark of Eli Lilly and Company.n
Marketed by: Lilly USA, LLCn
Indianapolis, IN 46285, USAn
Copyright u00a9 2019, Eli Lilly and Company. All rights reserved.n
This Instructions for Use has been approved by the U.S. Food and Drug AdminstrationIssued: July 2019BAQ-0001-IFU-20190724n

NDC 0002-6145-27n
baqsimin
(glucagon) nasal powdern
3 mgn
For Treatment of Severe Low Blood Sugarn
For Nasal Use Onlyn
Contains 2 nasal devices.n
Keep tubes sealed until ready to use.n
Rx onlyn
BAQSIMI Two Packn
www.baqsimi.comn
Lillyn

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Get Price

Glucagon (Baqsimi)

Trade Name : Baqsimi

POWDER

Delivery Process

Product information is meant for

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

Packaging and Delivery

About GNH

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Fluoxetine Hydrochloride (Fluoxetine)

Metoprolol Succinate (Metoprolol Succinate)

Losartan Potassium (Losartan Potassium)

Browse Our Services And Processes

Disclaimer

Browse from other international pharmaceuticals

General

US NDC

Canadian DIN

Swiss Drugs

NZ Drugs

FAQ

Can’t find what
you’re looking for?

COMPANY

SERVICES

QUICK LINKS

CONTACT US

Glucagon (Baqsimi)

Trade Name : Baqsimi

POWDER

Delivery Process

Product information is meant for

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

Packaging and Delivery

About GNH

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Fluoxetine Hydrochloride (Fluoxetine)

Metoprolol Succinate (Metoprolol Succinate)

Losartan Potassium (Losartan Potassium)

Browse Our Services And Processes

Disclaimer

Browse from other international pharmaceuticals

General

US NDC

Canadian DIN

Swiss Drugs

NZ Drugs

FAQ

Can’t find what you’re looking for?

COMPANY

SERVICES

QUICK LINKS

CONTACT US

Can’t find what
you’re looking for?